The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells
Stefania Fiorcari(The University of Texas MD Anderson Cancer Center), Jan A. Burger(The University of Texas MD Anderson Cancer Center)
Cited by 87
Related Papers
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
|Blood|2005|1.2k
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
|Blood|2009|576
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
|Nature Communications|2016|345